DIA Europe 2019 has ended
avatar for Nadia Assenova

Nadia Assenova

Sage Therapeutics
Head Regulatory Affairs Europe
Nadia Assenova MPharm, MBA, MSc is Head of Regulatory Affairs Europe at Sage Pharmaceuticals GmbH. She has more than 15 years of global regulatory strategy experience spanning across a variety of therapeutic areas and development stages. Nadia started her career at Novartis Pharma GmbH where she held roles of growing responsibility during her 12 year tenure. She then supported the EU strategy and Centralized procedures as Director at Cubist Pharmaceuticals Inc., and most recently focused on orphan products' development and life cycle at Alexion Pharma GmbH. She’s currently responsible for setting up the regulatory strategy and affiliate structure in Europe for for Sage’s CNS focused portfolio of products.